Revised structure of deacetyl-1,10-didehydrosalvinorin G.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Tetrahedron Letters

• Publication date

  2007-07-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.TETLET.2007.05.179PMID 18665199PMCID PMC2390872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.

  2007cited by this paper
• Unambiguous NMR spectral assignments of salvinorin A

  2007cited by this paper
• 8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor

  2007cited by this paper
• Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.

  2006cited by this paper
• Synthesis of salvinorin A analogues as opioid receptor probes.

  2006cited by this paper
• Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.

  2006cited by this paper
• The chemistry of Salvia divinorum

  2006cited by this paper
• Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).

  2006cited by this paper
• Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2).

  2005cited by this paper
• Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.

  2005cited by this paper
• Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues.

  2005cited by this paper
• New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.

  2005cited by this paper
• Autoxidation of salvinorin A under basic conditions.

  2005cited by this paper
• Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.

  2005cited by this paper
• Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.

  2005cited by this paper
• Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum Is a Highly Efficacious κ-Opioid Receptor Agonist: Structural and Functional Considerations

  2004cited by this paper
• Determination of the absolute stereochemistry of lupane triterpenoids by fucofuranoside method and ORD spectrum

  2004cited by this paper
• Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A.

  2003cited by this paper
• Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor.

  2003cited by this paper
• Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

  2002cited by this paper
• Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

  2002cited by this paper
• Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum.

  2001cited by this paper
• Salvia divinorum and salvinorin A: new pharmacologic findings.

  1994cited by this paper
• Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum

  1984cited by this paper
• Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae)

  1982cited by this paper

• Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A

  2024cites this paper
• Natural products for the treatment of pain: chemistry and pharmacology of salvinorin A, mitragynine and collybolide.

  2020cites this paper
• Clerodane diterpenes: sources, structures, and biological activities.

  2016cites this paper
• Neoclerodanes as atypical opioid receptor ligands.

  2013cites this paper
• 2012 David W. Robertson Award for Excellence in Medicinal Chemistry: Neoclerodanes as Atypical Opioid Receptor Ligands⊥

  2013cites this paper
• Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A

  2011cites this paper
• Natural Products from the Hallucinogenic Sage

  2010cites this paper
• Novel neoclerodane diterpene derivatives from the smoke of salvinorin A.

  2010cites this paper
• Thermal degradation products derived from the smoke of Salvia divinorum leaves

  2010cites this paper
• Second-generation synthesis of salvinorin A

  2009cites this paper
• Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse.

  2009cites this paper
• Chapter 5.3 Five-membered ring systems: Furans and benzofurans

  2009cites this paper
• Highly Oxygenated Diterpenoids Associated to the Central Nervous System : Syntheses of Salvinorin and Forskolin

  2009cites this paper
• Salvinorin A analogs as probes in opioid pharmacology.

  2008cites this paper
• Synthesis of deacetyl-1,10-didehydrosalvinorin G.

  2008cites this paper
• Total synthesis of the hallucinogenic neoclerodane diterpenoid salvinorin A.

  2008cites this paper